Deferred Tax Assets, Valuation Allowance of Benitec Biopharma Inc. from 30 Jun 2019 to 30 Jun 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Benitec Biopharma Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 30 Jun 2019 to 30 Jun 2025.
  • Benitec Biopharma Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 30 Jun 2025 was $25,044,000, a 22% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Benitec Biopharma Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $25,044,000 +$4,450,000 +22% 30 Jun 2025 10-K 22 Sep 2025 2025 FY
Q2 2024 $20,594,000 -$1,329,000 -6.1% 30 Jun 2024 10-K 22 Sep 2025 2025 FY
Q2 2023 $21,923,000 +$3,958,000 +22% 30 Jun 2023 10-K 26 Sep 2024 2024 FY
Q2 2022 $17,965,000 +$1,742,000 +11% 30 Jun 2022 10-K 21 Sep 2023 2023 FY
Q2 2021 $16,223,000 +$2,933,000 +22% 30 Jun 2021 10-K 02 Sep 2022 2022 FY
Q2 2020 $13,290,000 +$2,215,000 +20% 30 Jun 2020 10-K 20 Sep 2021 2021 FY
Q2 2019 $11,075,000 30 Jun 2019 10-K 23 Sep 2020 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.